Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
VZ Verizon Communications Inc
CETX Cemtrex Inc
RNXT RenovoRx Inc
BNTX BioNTech SE
ARTW Art's Way Manufacturing Co Inc
ARIZU Arisz Acquisition Corp
OSH Oak Street Health Inc
LESL Leslie's Inc
AAPL Apple Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Premarket

Last Trade
Delayed
$0.68
0.0003 (0.04%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.6797
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
596

10-day average volume:
1,510,376
596
  • Prev Close
    0.6797
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    4:00p ET 03/27/23
  • Last (size)
    27
  • 52-Wk Range
    0.315 - 1.57
    LowHigh
  • (08/15/22 - 12/27/22)
    115.78%
  • 112.1%
  • Market Cap
    137.9M
  • Shares Outstanding
    202.8M
  • -0.43
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.2
  • 22.42
  • (% of float 02/28/23)
    2.50

Latest News

March 22, 2023
8:00 am ET
BusinessWire
March 17, 2023
7:00 am ET
BusinessWire
February 10, 2023
10:56 am ET
PR Newswire
February 08, 2023
7:00 am ET
BusinessWire
February 03, 2023
11:00 am ET
BusinessWire
9:59 am ET
Accesswire
8:30 am ET
BusinessWire
5:45 am ET
PR Newswire
February 02, 2023
7:17 pm ET
Accesswire
6:06 pm ET
Newsfile
4:52 pm ET
Newsfile
10:01 am ET
Newsfile
8:30 am ET
BusinessWire
5:45 am ET
PR Newswire
February 01, 2023
6:15 pm ET
PR Newswire
5:36 pm ET
Newsfile
4:40 pm ET
Newsfile
11:03 am ET
Accesswire
9:13 am ET
Newsfile
5:45 am ET
PR Newswire
January 31, 2023
10:47 pm ET
Newsfile
4:28 pm ET
Newsfile
2:45 pm ET
Accesswire
12:15 pm ET
Accesswire
11:01 am ET
Accesswire
9:11 am ET
Newsfile
7:00 am ET
BusinessWire
5:45 am ET
PR Newswire
January 30, 2023
5:05 pm ET
Accesswire
11:01 am ET
Accesswire
9:10 am ET
Newsfile
5:45 am ET
PR Newswire
January 29, 2023
11:30 pm ET
Newsfile
2:03 pm ET
Globe Newswire
11:15 am ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.